Trevena Inc. (TRVN): Wutah pendapatan kuartal marang kuartal

Logo korporat perusahaan Trevena Inc (TRVN)

Trevena, Inc. is currently in an operational defense mode, attempting to overcome challenges with the commercialization of its primary analgesic. The development of modern painkillers for inpatient settings ensures steady sales through hospital formularies. Revenues are based on the treatment of neurological pathologies and acute pain. The quarterly revenue growth rate reflects expanding operations, with the indicator standing at -89.70.

TRVN (Trevena Inc) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 19.10.2024

Trevena Inc. (TRVN) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
- data kapitalisasi bursa:
Analisis umum perusahaan:Trevena, Inc. - TRVN
Barang unggulan Trevena

To assess the financial stability of Trevena, Inc. (TRVN), analyzing cash flow dynamics is critical, as calculating the relative change in quarterly sales helps identify business scaling rates prior to a market revaluation. The current level of quarter-over-quarter revenue growth reflects the company's ability to generate income amid geopolitical restrictions and logistical disruptions that are slowing the certification of neurological drugs and the conduct of international trials.

Analisis pesaing Trevena, Inc.

BIIB - Wutah pendapatan kuartal marang kuartal|NBIX (Neurocrine Biosciences) - Wutah dodolan kuartal marang kuartal|RGC: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Axsome (AXSM)|Wutah pendapatan kuartal marang kuartal ACADIA Pharmaceuticals Inc|Wutah dodolan triwulanan Xenon Pharmaceuticals Inc (XENE)|Wutah pendapatan triwulanan VKTX|Wutah pendapatan triwulanan supernus.com (SUPN)|Wutah pendapatan kuartal marang kuartal Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Dinamika pendapatan kuartal marang kuartal|Harmony Corp - Wutah pendapatan triwulanan|BHVN: Wutah pendapatan kuartal marang kuartal|AMLX: Wutah pendapatan triwulanan|TRVI: Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Praxis Medicines|Tingkat wutah pendapatan sajrone kuartal Anavex AVXL|Wutah pendapatan kuartal marang kuartal CeriBell Corp (CBLL)|Owah-owahan dodolan kuartal marang kuartal PRTA|Wutah pendapatan triwulanan ALEC (Alector)|Annexon (ANNX) - Tingkat wutah pendapatan sajrone kuartal|OMER - Wutah pendapatan kuartal marang kuartal|NGNE (Neurogene) - Wutah dodolan kuartal marang kuartal|ACIU: Wutah pendapatan triwulanan|VYGR - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Neumora Therapeutics, Inc.|Wutah dodolan kuartal marang kuartal SCLX (Scilex)|Wutah dodolan triwulanan TVGN (Tevogen Bio)|Wutah pendapatan triwulanan Alpha Cognition Inc (ACOG)|Wutah pendapatan triwulanan CGTX (cogrx.com)|Tingkat wutah dodolan sajrone kuartal Inhibikase Pharma (IKT)|SAVA: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Assertio ASRT|COYA (coyatherapeutics.com) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal VTGN|OVID (Ovid Therapeutics) - Wutah pendapatan triwulanan|Acumen Pharmaceuticals, Inc (ABOS) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal CervoMed, Inc. (CRVO)|ATHE - Tingkat wutah pendapatan sajrone kuartal|Wutah pendapatan triwulanan CLNN (Clene Inc.)|Tingkat wutah dodolan sajrone kuartal PepGen Inc. (PEPG)|JUNS - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Relmada Corp|ANVS (Annovis Bio, Inc.) - Wutah dodolan triwulanan|Grace Tx (GRCE) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan AIFF|Wutah pendapatan triwulanan anewmeds.com|Wutah pendapatan kuartal marang kuartal NeuroSense Therapeutics (NRSN)|RVPH (Reviva Pharmaceuticals Holdings) - Tambahing pendapatan triwulanan|MetaVia - Wutah dodolan triwulanan|NRXS: Wutah dodolan kuartal marang kuartal|Helius Medical Technologies, Inc. - Wutah pendapatan triwulanan|PASG: Wutah pendapatan kuartal marang kuartal|Neuphoria (NEUP) - Wutah pendapatan kuartal marang kuartal|Minerva Neurosciences - Tambahing pendapatan triwulanan|ATHA (Athira Pharma, Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal addextherapeutics.com ADXN|Wutah dodolan triwulanan ALZN (Alzamend Neuro Inc.)|CYCN (Cyclerion Therapeutics, Inc.) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan PTIX (Protagenic)|Wutah pendapatan triwulanan pasitheaclinics.com KTTA|CRGT - Wutah pendapatan kuartal marang kuartal|Tambahing pendapatan triwulanan ATXI (Avenue Therapeutics)|BCLI: Wutah pendapatan triwulanan|Cara Therapeutics - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Chromocell Therapeutics Corporation|Wutah pendapatan triwulanan Eliem Therapeutics Inc.|Wutah pendapatan kuartal marang kuartal Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan MRNS (marinuspharma.com)|NKGN: Wutah dodolan kuartal marang kuartal|NRBO - Wutah pendapatan kuartal marang kuartal|SAGE - Wutah pendapatan triwulanan|Synaptogenix (SNPX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Vigil Neuroscience (VIGL)|Wutah pendapatan kuartal marang kuartal Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal